Autophagy Signaling
-
3-Methyladenine
Catalog No. A11151 Autophagy/PI3K Inhibitor3-Methyladenine is an inhibitor of class III phosphatidylinositol 3-kinase (PI 3-kinase). Learn More -
SMER28
Catalog No. A15867 Autophagy ActivatorSMER28 is a small-molecule enhancer (SMER) of autophagy, inducing autophagy independently of rapamycin in mammalian cells. Learn More -
PIK-III
Catalog No. A15868 Autophagy InhibitorPIK-III is a selective inhibitor of ?VPS34 enzymatic activity. Learn More -
Monensin sodium
Catalog No. A10603 autophagy inhibitorMonensin sodium is an ionophore and inhibitor of autophagy commercially used in livestock feed. It inhibits autophagy, interfering with the fusion of the autophagosome and the lysosome. Learn More -
ROC-325
Catalog No. A17031 Autophagy inhibitorROC-325 is an autophagy inhibitor. ROC-325 exhibited superior in vitro anticancer effects compared with the existing autophagy inhibitor hydroxychloroquine (HCQ) in 12 different cancer cell lines with diverse genetic backgrounds. Learn More -
-
New
Autophinib
Catalog No. A17241 Autophagy inhibitorAutophinib is a novel potent autophagy inhibitor, inhibiting autophagy induced by starvation or Rapamycin by targeting the lipid kinase VPS34. Learn More -
-
ALLO-1
Catalog No. A18670 autophagy receptorALLO-1, an autophagy receptor, is essential for autophagosome formation around paternal organelles and directly binds to the worm LC3 homologue LGG-1 through its LC3-interacting region (LIR) motif. Learn More -
IITZ-01
Catalog No. A20192 Lysosomotropic autophagy inhibitorIITZ-01 is a potent lysosomotropic autophagy inhibitor with single-agent antitumor activity, with an IC50 of 2.62 μM for PI3Kγ. Learn More -
EACC
Catalog No. A19062 Autophagy inhibitorEACC is a reversible autophagy inhibitor, which can block autophagic flux. EACC selectively inhibits the translocation of autophagosome-specific SNARE Stx17 thereby blocking autophagosome-lysosome fusion. Learn More -
Aumitin
Catalog No. A18838 Autophagy inhibitorAumitin is an autophagy inhibitor, targeting mitochondrial complex I. Aumitin inhibits starvation- and rapamycin induced autophagy dose dependently with IC50s of 0.12 μM and 0.24 μM, respectively. Learn More -
EN6
Catalog No. A18524 Autophagy activatorEN6 is a novel covalent autophagy activator, targeting cysteine 277 in the ATP6V1A subunit of the lysosomal v-ATPase, which activates mTORC1 via the Rag guanosine triphosphatases. Learn More -
QX77
Catalog No. A13379 autophagy (CMA) activatorQX77 is a chaperone-mediated autophagy (CMA) activator. Learn More -
Lys01 trihydrochloride
Catalog No. A21702 lysosomal autophagy inhibitorLys01 trihydrochloride (Lys05) is a novel lysosomal autophagy inhibitor with IC50 values of 3.6, 3.8, 6 and 7.9 μM for 1205Lu, c8161, LN229 and HT-29 cell line in the MTT assay. Learn More -
Chloroquine Phosphate
Catalog No. A16445 Chloroquine phosphate is a 4-aminoquinoline anti-malarial and anti-rheumatoid agent, also acting as an ATM activator. Learn More -
Azithromycin Dihydrate
Catalog No. A16421 Azithromycin Dihydrate is an acid stable orally administered macrolide antimicrobial drug, structurally related to erythromycin. Learn More -
Lys05
Catalog No. A16358 Autophagy inhibitorLys05 is a potent lysosomal autophagy inhibitor. Lys05 is a previously undescribed dimeric chloroquine which more potently accumulates in the lysosome and blocks autophagy compared with HCQ. Learn More -
Scutellarein
Catalog No. A12234 Scutellarin, a main active ingredient extracted from Erigeron breviscapus (Vant.) Hand-Mazz, has been wildly used to treat acute cerebral infarction and paralysis induced by cerebrovascular diseases. Learn More -
MRT68921
Catalog No. A15880 Autophagy ULK1/2 inhibitorMRT68921 is a potent and dual autophagy kinase ULK1/2 inhibitor with IC50 of 2.9 nM and 1.1 nM, respectively. Learn More -
SBI-0206965
Catalog No. A15795 ULK1 inhibitorSBI-0206965 is a potent, selective and cell permeable autophagy kinase ULK1 inhibitor with IC50 of 108 nM for ULK1 kinase activity and 711 nM for the highly related kinase ULK2 . Learn More -
SBC-115076
Catalog No. A15769 PCSK9 antagonistSBC-115076 is an anti-proprotein convertase subtilisin kexin type 9 (anti-PCSK9) compounds, for the treatment and/or prevention of cardiovascular diseases. Learn More -
Spautin-1
Catalog No. A12942 Autophagy InhibitorSpautin-1 is a novel autophagy inhibitor, IM inhibited the growth of K562 cells with IC50 of 1.03μM. In contrast, co-treatment with Spautin-1 increased IM-induced inhibition of cell viability with IC50 of 0.45 μM. Learn More -
Hydroxychloroquine Sulfate
Catalog No. A14208 Hydroxychloroquine Sulfate is an antimalarial agent used for the treatment of systemic lupus erythematosus, rheumatoid arthritis and other autoimmune, inflammatory and dermatologic conditions. Also acts as an inhibitor of autophagy and toll-like receptor (TLR) 7/9. Learn More -
Flubendazole (Flutelmium)
Catalog No. A11656 autophagy inducerFlubendazole is an anthelmintic used for protection against internal parasites and worms in dogs and cats. Learn More -
Resveratrol
Catalog No. A10785 Resveratrol has a wide spectrum of targets including cyclooxygenases(i.e. COX, IC50=1.1 μM), lipooxygenases(LOX, IC50=2.7 μM), kinases, sirtuins and other proteins. It has anti-cancer, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects. Learn More -
STF-62247
Catalog No. A10866 Autophagy InducerSTF-62247 is a small molecule agonist that induces autophagy and selectively causes lethality in renal cell carcinoma (RCC) cells that have lost the von Hippel-Lindau (VHL) tumor suppressor activity (IC50 = 625 nM). Learn More -
PF-06454589
Catalog No. A22595 -
LRRK2-IN-1
Catalog No. A11477 LRRK2 inhibitorLRRK2-IN-1 inhibits both G2019S mutant and wild-type LRRK2 kinase activity with IC50 values of 6 and 13 nM respectively. Learn More -
MLi-2
Catalog No. A20530 brain penetrant LRRK2 inhibitorMLi-2 is a potent, highly selective, orally available, brain penetrant inhibitor of LRRK2 with an IC50 of 0.76 nM. Learn More -
LRRK2 inhibitor 1
Catalog No. A19701 LRRK2 inhibitorLRRK2 inhibitor 1 is a potent, selective and oral LRRK2 inhibitor with an pIC50 of 6.8 nM. Learn More -
PF-06447475
Catalog No. A15504 LRRK2 inhibitorPF-06447475 is a highly potent, selective, brain penetrant LRRK2 inhibitor with IC50 of 3 nM/11 nM for Wt LRRK2/G2019S LRRK2 respectively. Learn More -
CZC54252 hydrochloride
Catalog No. A15510 LRRK2 inhibitorCZC-54252 is a potent inhibitor of LRRK2 with IC50s of 1.28 nM and 1.85 nM for wild-type and G2019S LRRK2 respectively. Learn More -
CZC-25146 hydrochloride
Catalog No. A13448 LRRK2 inhibitorCZC-25146 is a potent and selective LRRK2 inhibitor. CZC-25146 prevents mutant LRRK2-induced injury of cultured rodent and human neurons with mid-nanomolar potency. Learn More -
TAE684
Catalog No. A10662 ALK InhibitorTAE684 is a inhibitor of ALK and also a potent inhibitor of LRRK2 kinase activity (IC(50) of 7.8nM against wild-type LRRK2, 6.1nM against the G2019S mutant). Learn More -
GNE-7915
Catalog No. A13748 LRRK2 inhibitorGNE-7915 is a Blood-Brain Barrier (BBB) penetrable small molecule inhibitor of Leucine-Rich Repeat Kinase 2 (LRRK2). Learn More -
GNE 9605
Catalog No. A14149 LRRK2 inhibitorGNE-9605 is a highly potent and selective leucine-rich repeat kinase 2 (LRRK2) inhibitor with Ki and IC50 of 2 nM and 19 nM, respectively. Learn More -
GSK2578215A
Catalog No. A12798 LRRK2 kinase inhibitorGSK2578215A is a potent leucine-rich repeat kinase 2 (LRRK2) inhibitor (IC50 values are 8.9 and 10.1 nM respectively for LRRK2[G2019S] mutant and wild-type LRRK2 respectively). Learn More -
-
New
CZC-25146
Catalog No. A17125 -
-
-
New
PF-06371900
Catalog No. A17221 LRRK2 inhibitorPF-06371900 is a potent and highly selective leucine rich repeat kinase 2 (LRRK2) inhibitor. Learn More -
-
PFE-360 (PF-06685360)
Catalog No. A18816 LRRK2 inhibitorPFE-360, also known asd PF-06685360, is a potent and selective inhibitor of LRRK2 kinase. Learn More -
HG-10-102-01
Catalog No. A12919 LRRK2 Inhibitor IIIHG-10-102-01 is a brain penetrant, potent and selective inhibitor of wild-type LRRK2. Learn More -
GNE0877
Catalog No. A13969 -
JH-II-127
Catalog No. A15777 LRRK2 inhibitorJH-II-127 is a highly potent, selective, and brain penetrant LRRK2 inhibitor, with IC50 of 6.6 nM, 2.2 nM ,47.7 nM for LRRK2-wild-type, LRRK2-G2019S, LRRK2-A2016T. Learn More -
PS372424
Catalog No. A19421 Human CXCR3 agonistPS372424, a three amino-acid fragment of CXCL10, is a specific human CXCR3 agonist with anti-inflammatory activity, which inhibits the binding of CXCR3 ligand CXCL10 to CXCR3 receptor with IC50 of 42 nM. Learn More -
AMD 3465 Hexahydrobromide
Catalog No. A11953 CXCR4 antagonistAMD 3465 is a potent, selective CXCR4 antagonist. Learn More -
NSC-23026
Catalog No. A17151 -
AMD 070
Catalog No. A11315 CXCR4 antagonistAMD 070 is a CXCR4 chemokine receptor antagonist. Learn More -
Kynurenic acid
Catalog No. A16581 GPR35/CXCR8 agonistKynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid is also an agonist of GPR35/CXCR8. Learn More -
Plerixafor 8HCl (DB06809)
Catalog No. A10913 CXCR4 antagonistPlerixafor is an immunostimulant used to multiply hematopoietic stem cells and it is a chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation. Learn More -
CXCR2-IN-1
Catalog No. A12649 CXCR2 antagonistsCXCR2-IN-1 is a central nervous system penetrant CXCR2 antagonists with a pIC50 of 9.3. Learn More -
GPR35 agonist 1
Catalog No. A12462 GPR35/CXCR8 agonistGPR35 agonist 1 (compound 50) is a potent and specific G protein-coupled receptor-35 (GPR35)/CXCR8 agonist with an EC50 of 5.8 nM, displays good druggability. Learn More